$DOW

Dow (NYSE: DOW) officer plans $482K stock sale

Dow Inc. officer Marco ten Bruggencate plans to sell 16,184 shares, valued at $482,150.55, on or after September 10, 2026. The shares were acquired between October 2024 and February 2026 via employee stock plans and restricted stock vesting.

Original reporting
Published Sep 10, 2026, 5:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DOW
Neutral
high confidence
Mentioned
$DOW
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$DOWNeutralLow
01

Why it matters

The filing adds supply to the market but the amount is small relative to Dow's float, so price impact is expected to be negligible.

02

Market read

A routine insider sale with limited market relevance.

03

What to watch

Potential upcoming corporate actions or market conditions that might amplify the sale's impact.

Relevance 4/10Novelty 5/10Timing: sale scheduled for on or after Sep 10 2026

Background

Form 144 filing discloses an insider's intent to sell restricted shares, a routine regulatory disclosure.

Company-level read

Ticker impact

$DOWNeutralHigh confidence
Context

Officer Marco ten Bruggencate filed a Rule 144 to sell 16,184 Dow shares (~$482k) on/after Sep 10, 2026.

Expected impact

minimal downward pressure, likely within normal trading range

Evidence & confidence

The transaction size is modest relative to Dow's market cap; insider sales of this magnitude rarely affect price.

Market effects

None significant; chemical sector unchanged.

No regional effect beyond Dow's own share supply.

Low; isolated insider transaction.

Counterpoint

If the insider is cashing out due to negative outlook, could signal future weakness.

Key entities

  • Marco ten Bruggencate

    Dow Inc. officer filing the Rule 144 sale.

  • Dow Inc.

    Chemical and materials company listed on NYSE under ticker DOW.

Related articles

$DOWMed

Dow Rethinks its $20 Billion Saudi Chemicals Bet

Dow Inc. (DOW) is considering selling its 35% stake in Sadara Chemical, a $20 billion joint venture with Saudi Aramco, to reduce financial pressure. As of June 30, Dow had a negative investment balance of $793 million in Sadara. The venture has faced operational disruptions and financial obligations, making it a burden for Dow. A sale could improve Dow's cash flow and align with its portfolio restructuring goals.

$DOWMed

Dow, X-Energy to receive $1 B in U.S. DOE funding for nuclear power project at Seadrift

X-energy said the U.S. Department of Energy told it it will receive $1 billion in additional public funding for a nuclear power project in Seadrift, Texas, with Dow Inc. Total DOE funding since 2021 could reach $2.15 billion. The award follows a 50/50 cost share. Dow and X-energy filed a NRC construction permit application, targeting early 2030s operations.

$LYBMed

Iran conflict lifts chemical earnings

Iran conflict and Strait of Hormuz disruption have tightened petrochemical supply, enabling major chemical makers to raise prices. LyondellBasell reported Q2 adjusted earnings of $1.4B, up nearly 600% YoY. Dow sales rose 19.7% and swung to profit. BASF profits rose 167% with 16% higher sales. Executives warn the boost may be temporary.